Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-04-25
2006-04-25
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
Reexamination Certificate
active
07034005
ABSTRACT:
The present invention relates to agent for suppressing infection and proliferation of human immunodeficiency syndrome virus (HIV-1), which infects immunocompetent cells such as macrophage or dendritic cell and causes destruction of immune system, and use of known compounds, macrolide derivatives for suppression of infection and proliferation of human immunodeficiency syndrome virus in M type macrophage derived from human monocytes. The present invention is useful for treatment of patients with HIV-1 infection by low cost chemotherapeutic agents, and in addition, is clinically used as supplement agent in HAART.
REFERENCES:
patent: 5106961 (1992-04-01), Kirst et al.
patent: 5514662 (1996-05-01), Seman
patent: 5541193 (1996-07-01), Kawai et al.
patent: 5545734 (1996-08-01), Baker et al.
patent: 0 254 534 (1988-01-01), None
patent: 1 064 942 (2001-01-01), None
Tae-Wook Chun, Richard T. Davey Jr., Mario Ostrowski, J., Shawn Justement, Delphine Engel, James I. Mullins & Anthony, S. Fauci: Relationship between pre-existing viral reservoires and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy, Nat Med 6: 757-761, 2000.
Lewis K. Schrager, M. Patricia D' Souza; Cellular and Anatomical Reservoirs of HIV-1 in Patients Receiving Potent Antiretroviral Combination Therapy, Jama 280: 67-71, 1998.
Swingler S, Mann A, Jacque J, Brichacek B, Sasseville VG, Williams K, Lackner AA, Janoff EN, Wang R, Fisher D, Stevenson M.: HIV-1 Nef mediates lymphocyte chemotaxis and activation By infected macrophages. Nat Med 5: 997-1003, 1999.
Kiyoko Akagawa, Iwao Komuro and Keiko Mochida: Deriversity of macrophage derived from monocytes, Inflammation and Immunity, vol. 8, 360-366, 2000.
Komuro, I., Keicho, N., Iwamoto, I., and Akagawa, K. S.: Human alveolar macrophages and GM-CSF-induced monocyte-derived macrophages and resistant to H2O2 via their high basal- and inducible-levels of catalase activity, J. Biol. Chem. 276: 24360-24364, 2001.
Hashimoto, S., Komuro, I., Yamada, M. Akagawa, K. S.: IL-10 inhibits GM-CSF-dependent human monocyte survival at the early stage of the culture and inhibits the generation of macrophages, J. Immunol. 167: 3619-3625, 2001.
Hashimoto, S., Yamada, M., Motoyoshi, K. and Akagawa, K. S.: Enhancement of macrophage-colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10, BLOOD 89: 315-321, 1997.
Akagawa, K. S., Takasuka, N., Nozaki, Y., Komuro, I., Miyuki, A., Ueda, M., Naito, M. and Takahashi, K.: Generation of CD1+ Re1B+ Dendritic Cells and TRAP-positive Osteociast-like Multi- nucleated Giant Cells from Human Monocytes, BLOOD 88: 4029-4039, 1996.
Matsuda, S., Akagawa, K., Honda, M., Yokota, Y., Takabe, Y. and Takemori, T.: Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor, AIDS Research and Human Retroviruses, 11: 1031-1038, 1995.
Inflammation,Immunity and Macrorides Up to Date, Ed. Sup. Kihachiro Shimizu and Satoshi Omura, Ed. Shoji Kudo: Iyaku Journal, Inc. Osaka, 1996.
Nakata, K., Weiden, M., Harkin, T., Ho, D. and Rom, W. N.(1995). Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol Med 1, 744-757.
Akagawa Kiyoko
Omura Satoshi
Sunazuka Toshiaki
Peselev Elli
The Kitasato Institute
Young & Thompson
LandOfFree
Use of agent for suppressing infection and proliferation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of agent for suppressing infection and proliferation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of agent for suppressing infection and proliferation of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3531212